LDHA and pancreatic neoplasm: Recent publications suggest that use of disulfiram, an irreversible inhibitor of ALDH [58], or dasatinib, a potent inhibitor of SRC family kinases and ABL kinases [59], in combination with chemotherapeutic drugs may be able to address this problem and slow the growth of pancreatic tumors.